Artelo Biosciences (ARTL) Net Equity Issued and Repurchased (2015 - 2026)
Artelo Biosciences' Net Equity Issued and Repurchased came in at $10.27 million for Q1 2026, up 483.4% from the prior quarter.
Powered by 
Analysis
Artelo Biosciences (ARTL) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, Artelo Biosciences reported Net Equity Issued and Repurchased of $16.55 million; for FY2025, it was $6.28 million.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 26.0% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $112,000 in FY2024 (-80.2%), $567,000 in FY2023 and $14.12 million in FY2021 (+613.8%).
- The Q1 2026 figure represents the highest quarterly Net Equity Issued and Repurchased in data going back to Q4 2015.
- Business Quant data shows ARTL's Net Equity Issued and Repurchased at $1.76 million (Q4 2025), $3.44 million (Q3 2025) and $1.08 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Artelo Biosciences | 49.32 Mn | 32.53 Mn | - | -59,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -59,000.00 |
| Mar 31, 2026 | 10.27 Mn |
| Dec 31, 2025 | 1.76 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Dec 31, 2024 | 57,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Sep 30, 2023 | 535,000.00 |
| Nov 30, 2021 | 18.26 Mn |
| Feb 28, 2021 | 6.34 Mn |
| Nov 30, 2020 | 6.58 Mn |
| Aug 31, 2020 | 1.60 Mn |
| Aug 31, 2019 | 6.70 Mn |
| May 31, 2019 | 417,732.00 |
| Feb 28, 2019 | 1.09 Mn |
| Nov 30, 2018 | 170,774.00 |
| Aug 31, 2018 | 525,827.00 |
| May 31, 2018 | 268,649.00 |
| Aug 31, 2017 | 770,521.00 |
API Access
Artelo Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();